Results 81 to 90 of about 2,720 (165)

EHA2024 Hybrid Congress

open access: yes
HemaSphere, Volume 8, Issue S1, June 2024.
wiley   +1 more source

Immunogenicity of recombinant vesicular stomatitis virus-vectored vaccines expressing the Machupo virus glycoprotein in different genome positions

open access: yesJournal of Virology
Recombinant vesicular stomatitis virus (rVSV) is a powerful vaccine platform that elicits durable cellular and humoral immune responses. rVSV vaccines have successfully been used for various hemorrhagic fever-causing viruses. Here, we create and evaluate
Rachel Erickson, Paul Bates
doaj   +1 more source

A review of emerging health threats from zoonotic New World mammarenaviruses

open access: yesBMC Microbiology
Despite repeated spillover transmission and their potential to cause significant morbidity and mortality in human hosts, the New World mammarenaviruses remain largely understudied.
Arianna Lendino   +3 more
doaj   +1 more source

[Immunopathology induced in the rat by Junin virus].

open access: yesRevista Argentina de microbiologia, 1991
Intra-cerebral infection of the 10-day-old rat with the XJ prototype strain of Junin virus induces an immunopathological encephalitis with 100% mortality. In contrast with previous observations, our present work with antithymocyte serum (ATS) demonstrates a pathological role for the cellular immune response in this experimental model.
M C, Remesar, J L, Blejer, M R, Nejamkis
openaire   +1 more source

Bovine Serum Albumin Nanoparticle-Mediated Delivery of Ribavirin and Mycophenolic Acid for Enhanced Antiviral Therapeutics

open access: yesViruses
The global spread of viral diseases is a public health issue. Ribavirin (RBV) and mycophenolic acid (MPA) are well-known wide-spectrum antiviral agents.
Mayra A. Castañeda Cataña   +7 more
doaj   +1 more source

Multi-epitope-based vaccine designing against Junín virus glycoprotein: immunoinformatics approach

open access: yesFuture Journal of Pharmaceutical Sciences
Background The Junín virus (JUNV) is well known for causing argentine haemorrhagic fever (AHF), a severe endemic disease in farming premises. The glycoprotein of JUNV is an important therapeutic target in vaccine design.
Mallari Praveen
doaj   +1 more source

Home - About - Disclaimer - Privacy